SB 1247 revises Missouri’s controlled substances law, section 195.070, to clarify which health professionals may prescribe, administer, dispense, or order controlled substances. The bill keeps the existing authority for physicians, dentists, podiatrists, optometrists with certification, assistant physicians, physician assistants, and advanced practice registered nurses with prescriptive authority, while expressly excluding certified registered nurse anesthetists from the advanced practice nurse prescribing provisions.
The main change is that certified registered nurse anesthetists (CRNAs) would be authorized to select, issue orders for, and administer controlled substances in Schedules II through V when providing anesthesia care to a patient in a licensed facility, but they would not be allowed to prescribe those drugs. The bill also states that CRNAs do not need to obtain a controlled substance prescriptive authority certificate from the board of nursing to exercise this anesthesia-care authority. The bill retains existing limits on APRN prescribing, including restrictions on Schedule II drugs and prohibitions on self- or family-prescribing, and it leaves in place rules on handling unused controlled substances and personal-use prescribing.
In practical terms, the bill would affect Missouri’s controlled substances framework by carving out a specific anesthesia-related authority for CRNAs while preserving the broader prescribing rules for other practitioners. It would amend section 195.070, RSMo, and would likely affect hospitals, surgical centers, anesthesia providers, nurses, pharmacists, and regulators overseeing controlled substance handling and professional scope of practice.
The overall sentiment appears supportive and technical rather than highly partisan, based on the bill’s narrow caption and the absence of recorded committee debate or votes in the provided materials. The bill seems aimed at clarifying practice authority and reducing regulatory barriers for CRNAs in licensed facilities. Because no transcript or vote history is provided, there is no evidence here of organized opposition or controversy in the legislative record supplied.
The main point of contention inherent in the bill is the scope of practice for certified registered nurse anesthetists: supporters would likely view the measure as a clarification of anesthesia practice authority, while critics could focus on the distinction between administering and prescribing controlled substances and on whether the change expands nursing authority too far. The bill also preserves a clear boundary by denying CRNAs general prescriptive authority, which may reflect an effort to balance access and oversight.
SB 1247 would amend section 195.070, RSMo, to create a specific statutory authority for certified registered nurse anesthetists to select, issue orders for, and administer Schedule II-V controlled substances during anesthesia care in licensed facilities, while expressly stating that this does not authorize prescribing and does not require a controlled substance prescriptive authority certificate. It would leave the existing controlled-substance prescribing framework for physicians and other listed practitioners largely intact, including the separate rules for advanced practice registered nurses, veterinarians, and restrictions on unused medications and personal use.
Based on the bill text and the lack of recorded committee testimony or votes in the provided materials, the bill appears to have a generally favorable, administrative, and scope-of-practice clarification tone rather than a contentious one. The measure is narrowly tailored to anesthesia practice and seems designed to resolve ambiguity for CRNAs without broadly changing controlled-substance policy.
The likely point of contention is professional scope of practice: whether CRNAs should have explicit statutory authority to order and administer controlled substances in anesthesia settings, and how that authority should be distinguished from prescribing. Supporters would likely emphasize patient access and operational clarity in licensed facilities, while opponents could worry about expanding non-physician authority over controlled substances. The bill’s explicit exclusion of CRNAs from the APRN prescribing subsection suggests an effort to address those concerns by limiting the change to anesthesia care.